Stock listing
OTC:ECHQF EchoIQ Limited Stock
US listing (OTC) of EchoIQ Limited · home listing ASX:EIQ
Follow EchoIQ Limited into a list and get an email when it puts out news.
Share price · OTC:ECHQF
$0.20 USD 0.00 (0.0%)
Close on Nov 20, 2026
- Day range
- $0.20 – $0.20 USDNov 20, 2026
- Market cap
- $148.2M USDAt the close on Nov 20, 2026 · price × 740.9M shares outstanding
- 52-week range
- $0.109 – $1.60 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $1,590 USDMedian day 0 shares · 45 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| ASX:EIQ · Home | $0.325 AUD | +0.050 (+18.2%) | 13,613,730 | $0.265 | $0.340 | $0.260 | $0.275 | Close on Nov 20, 2026 |
| OTC:ECHQF | $0.20 USD | 0.00 (0.0%) | — | $0.20 | $0.20 | $0.20 | $0.20 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · OTC:ECHQF · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.20 | 0.00 | 0.0% | $0.20 | $0.20 | $0.20 | 0 | |
| $0.20 | -0.17 | -45.9% | $0.109 | $0.20 | $0.109 | 11,803 | |
| $0.37 | 0.00 | 0.0% | $0.37 | $0.37 | $0.37 | 0 | |
| $0.37 | 0.00 | 0.0% | $0.37 | $0.37 | $0.37 | 0 | |
| $0.37 | 0.00 | 0.0% | $0.37 | $0.37 | $0.37 | 0 | |
| $0.37 | 0.00 | 0.0% | $0.37 | $0.37 | $0.37 | 0 | |
| $0.37 | +0.07 | +23.3% | $0.37 | $0.37 | $0.37 | 6,000 | |
| $0.30 | -0.04 | -11.8% | $0.30 | $0.30 | $0.30 | 600 | |
| $0.34 | +0.04 | +13.3% | $0.34 | $0.34 | $0.278 | 70,614 | |
| $0.30 | 0.00 | 0.0% | $0.30 | $0.30 | $0.30 | 0 | |
| $0.30 | 0.00 | 0.0% | $0.30 | $0.30 | $0.30 | 0 | |
| $0.30 | 0.00 | 0.0% | $0.30 | $0.30 | $0.30 | 30,000 | |
| $0.30 | 0.00 | 0.0% | $0.30 | $0.30 | $0.30 | 32,338 | |
| $0.30 | 0.00 | 0.0% | $0.30 | $0.30 | $0.30 | 662 | |
| $0.30 | -0.07 | -18.9% | $0.286 | $0.36 | $0.249 | 2,689 | |
| $0.37 | 0.00 | 0.0% | $0.37 | $0.37 | $0.37 | 0 | |
| $0.37 | 0.00 | 0.0% | $0.37 | $0.37 | $0.37 | 0 | |
| $0.37 | -0.13 | -26.0% | $0.37 | $0.37 | $0.37 | 15,000 | |
| $0.50 | +0.14 | +38.9% | $0.35 | $0.50 | $0.35 | 23,000 | |
| $0.36 | +0.14 | +63.9% | $0.36 | $0.36 | $0.36 | 25,000 | |
| $0.22 | 0.00 | 0.0% | $0.22 | $0.22 | $0.22 | 0 | |
| $0.22 | 0.00 | 0.0% | $0.22 | $0.22 | $0.22 | 0 | |
| $0.22 | -0.14 | -39.0% | $0.22 | $0.22 | $0.22 | 500 | |
| $0.36 | 0.00 | 0.0% | $0.36 | $0.36 | $0.36 | 0 | |
| $0.36 | 0.00 | 0.0% | $0.36 | $0.36 | $0.36 | 0 | |
| $0.36 | 0.00 | 0.0% | $0.36 | $0.36 | $0.36 | 0 | |
| $0.36 | 0.00 | 0.0% | $0.36 | $0.36 | $0.36 | 0 | |
| $0.36 | 0.00 | 0.0% | $0.36 | $0.36 | $0.36 | 0 | |
| $0.36 | +0.01 | +2.9% | $0.35 | $0.36 | $0.35 | 28,000 | |
| $0.35 | +0.002 | +0.5% | $0.34 | $0.35 | $0.291 | 33,000 | |
| $0.348 | 0.00 | 0.0% | $0.348 | $0.348 | $0.348 | 0 | |
| $0.348 | 0.00 | 0.0% | $0.348 | $0.348 | $0.348 | 0 | |
| $0.348 | 0.00 | 0.0% | $0.348 | $0.348 | $0.348 | 0 | |
| $0.348 | 0.00 | 0.0% | $0.348 | $0.348 | $0.348 | 0 | |
| $0.348 | 0.00 | 0.0% | $0.348 | $0.348 | $0.348 | 0 | |
| $0.348 | 0.00 | 0.0% | $0.348 | $0.348 | $0.348 | 0 | |
| $0.348 | 0.00 | 0.0% | $0.348 | $0.348 | $0.348 | 0 | |
| $0.348 | 0.00 | 0.0% | $0.348 | $0.348 | $0.348 | 0 | |
| $0.348 | 0.00 | 0.0% | $0.348 | $0.348 | $0.348 | 0 | |
| $0.348 | 0.00 | 0.0% | $0.348 | $0.348 | $0.348 | 0 | |
| $0.348 | 0.00 | 0.0% | $0.348 | $0.348 | $0.348 | 0 | |
| $0.348 | 0.00 | 0.0% | $0.348 | $0.348 | $0.348 | 0 | |
| $0.348 | 0.00 | 0.0% | $0.348 | $0.348 | $0.348 | 0 | |
| $0.348 | 0.00 | 0.0% | $0.348 | $0.348 | $0.348 | 0 | |
| $0.348 | 0.00 | 0.0% | $0.348 | $0.348 | $0.348 | 0 | |
| $0.348 | 0.00 | 0.0% | $0.348 | $0.348 | $0.348 | 0 | |
| $0.348 | 0.00 | 0.0% | $0.348 | $0.348 | $0.348 | 0 | |
| $0.348 | 0.00 | 0.0% | $0.348 | $0.348 | $0.348 | 0 | |
| $0.348 | 0.00 | 0.0% | $0.348 | $0.348 | $0.348 | 0 | |
| $0.348 | -0.152 | -30.3% | $0.493 | $0.493 | $0.348 | 12,000 | |
| $0.50 | +0.014 | +2.9% | $0.50 | $0.50 | $0.50 | 700 | |
| $0.486 | 0.00 | 0.0% | $0.486 | $0.486 | $0.486 | 0 | |
| $0.486 | -0.414 | -46.0% | $0.60 | $0.655 | $0.486 | 5,500 | |
| $0.90 | 0.00 | 0.0% | $0.90 | $0.90 | $0.90 | 0 | |
| $0.90 | 0.00 | 0.0% | $1.20 | $1.20 | $0.90 | 200 | |
| $0.90 | 0.00 | 0.0% | $0.90 | $0.90 | $0.90 | 0 | |
| $0.90 | 0.00 | 0.0% | $0.90 | $0.90 | $0.90 | 300 | |
| $0.90 | 0.00 | 0.0% | $0.90 | $0.90 | $0.90 | 0 | |
| $0.90 | 0.00 | 0.0% | $0.90 | $0.90 | $0.90 | 0 | |
| $0.90 | -0.30 | -25.0% | $0.90 | $0.90 | $0.90 | 200 | |
| $1.20 | 0.00 | 0.0% | $1.20 | $1.20 | $1.20 | 0 | |
| $1.20 | 0.00 | 0.0% | $1.20 | $1.20 | $1.20 | 0 | |
| $1.20 | +0.10 | +9.1% | $1.20 | $1.20 | $1.20 | 200 | |
| $1.10 | 0.00 | 0.0% | $1.10 | $1.10 | $1.10 | 0 | |
| $1.10 | 0.00 | 0.0% | $1.10 | $1.10 | $1.10 | 0 | |
| $1.10 | 0.00 | 0.0% | $1.10 | $1.10 | $1.10 | 0 | |
| $1.10 | -0.02 | -1.8% | $1.10 | $1.10 | $1.10 | 2,000 |
- Ticker
- OTC:ECHQF
- Asset type
- Stock
- Sector
- Health care
- Industry
- Health care services
- Exchange
- OTC
- Currency
- USD
What changed lately
Latest news release · Nov 20, 2026
Cleansing Notice
Latest deck · Nov 17, 2026
Bell Potter Healthcare Conference 2026
Conference · 22 slides
Latest news
Cleansing Notice
Nov 19, 2026
Closed $0.20 (0.0%) on Nov 20, 2026
Application for quotation of securities - EIQ
Nov 19, 2026
Closed $0.20 (0.0%) on Nov 20, 2026
EchoSolv HF regulatory update
Nov 18, 2026
Closed $0.20 (-45.9%) on Nov 19, 2026
Trading Halt
Nov 18, 2026
Closed $0.20 (-45.9%) on Nov 19, 2026
Pause in Trading
Nov 18, 2026
Closed $0.20 (-45.9%) on Nov 19, 2026
Bell Potter Healthcare Conference Presentation
Nov 16, 2026
Closed $0.37 (0.0%) on Nov 17, 2026
Dr Vasum Peiris Appointed as Chief Medical Officer
Nov 15, 2026
Closed $0.37 (0.0%) on Nov 16, 2026
Notification regarding unquoted securities - EIQ
Nov 4, 2026
Closed $0.30 (0.0%) on Nov 4, 2026
Quarterly Activities Report & Appendix 4C Cashflow Report
Oct 25, 2026
Closed $0.36 (+63.9%) on Oct 26, 2026
Notice of Annual General Meeting/Proxy Form
Oct 23, 2026
Closed $0.22 (0.0%) on Oct 23, 2026
EchoIQ Limited on 6ix
- Sector
- Health care
- Industry
- Health care services
- News releases
- 55 in the last 12 months · 245 in all · newest Nov 20, 2026 · oldest 2016
- Decks
- 12 decks · latest Nov 17, 2026
Where EchoIQ Limited is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| ASX:EIQ · Home listing | ASX | Australia | AUD |
| gettex:PL4 | gettex | Germany | EUR |
| OTC:ECHQF · This page | OTC | United States | USD |
| Tradegate:PL4 | Tradegate | Germany | EUR |
| LS Exchange:A3C84A | LS Exchange | Germany | EUR |
| Lang & Schwarz:A3C84A | Lang & Schwarz | Germany | EUR |
| Hamburg:PL4 | Hamburg | Germany | EUR |
| Frankfurt:PL4 | Frankfurt | Germany | EUR |
| Munich:PL4 | Munich | Germany | EUR |
| Stuttgart:PL4 | Stuttgart | Germany | EUR |
Valuation
EV/sales 2,523× against a median of 0.9×: the highest of 11 Health care services companies shown. Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- $232.1M AUD
- P/E
- Loss
- EV/sales
- 2,523×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 20.7×
- Gross margin
- Revenue too small
- Operating margin
- Revenue too small
- Net margin
- Revenue too small
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Health care services: the 10 companies nearest in size, of 419 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| EchoIQ Limited · ASX:EIQ | US$159.4M | US$153.6M | n/a | 2,523× | n/a | 20.7× | n/a | 0.0× | n/a |
| PT Prodia Widyahusada Tbk · IDX:PRDA | US$166.2M | US$128.9M | 13.9× | 1.0× | 4.7× | 1.3× | 9.0% | 0.0× | n/a |
| American Well Corporation · NYSE:AMWL | US$165.1M | −US$13.64M | n/a | −0.1× | n/a | 0.8× | −27.0% | 0.0× | 0.96 |
| PT Nitrasanata Dharma Tbk · IDX:JECX | US$163.0M | US$148.8M | 41.1× | 2.9× | 13.9× | 3.0× | 7.8% | 0.0× | n/a |
| Rici Healthcare Holdings Ltd. · HKEX:1526 | US$162.9M | US$282.0M | 3.5× | 0.7× | 1.7× | 0.7× | 11.0% | 1.1× | n/a |
| Carasent AB · OMXSTO:CARA | US$161.2M | US$159.0M | 41.7× | 4.2× | 18.9× | 2.0× | 10.1% | 0.0× | n/a |
| Srivichaivejvivat Public Co. Ltd. · SET:VIH | US$158.4M | US$118.6M | 12.0× | 1.3× | 5.5× | 1.4× | 14.3% | 0.0× | n/a |
| ILEX Medical Ltd. · TASE:ILX | US$157.2M | US$107.2M | 13.6× | 0.4× | 4.0× | 0.8× | 4.4% | 0.1× | n/a |
| Profarma Distribuidora de Produtos Farmaceuticos SA · BMFBOVESPA:PFRM3 | US$154.2M | US$392.9M | 5.9× | 0.2× | 3.7× | 0.6× | 1.2% | 1.3× | n/a |
| Rajthanee Hospital Public Company Limited · SET:RJH | US$153.8M | US$169.2M | 14.0× | 2.0× | 9.9× | 2.3× | 12.7% | 0.3× | n/a |
| Bastide Le Confort Medical SA · EURONEXT:BLC | US$153.5M | US$428.9M | 2.4× | 0.8× | 3.7× | 1.1× | 12.0% | 2.3× | n/a |
| Median of the others | US$159.8M | US$153.9M | 13.6× | 0.9× | 4.7× | 1.2× | 9.6% | 0.1× | 0.96 |
Forecasts
Analysts' consensus from EODHD, read Nov 15, 2026. Not 6ix's view and not investment advice.
- Price target
- 0.91 AUD · Analysts' mean
- EPS, year to Jun 2027
- -0.020 · 4 analysts
- Revenue, year to Jun 2027
- 2.04M · 2 analysts
Team and board
| Officer | Role |
|---|---|
| Dustin Haines | Chief Executive Officer |
| Matthew Dodds | Chief Financial Officer |
| Nick Lubbers | US President and General Manager |
| Dane Brescacin | SVP Regulatory Affairs |
| Patrick O’Shea | Head of Strategy & Operations |
| Sam Dribin | Chief Technology Officer |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q2 2025 | Aug 29, 2025 · Before open | −2.3% |
| Q4 2024 | Feb 27, 2025 | −6.9% |
| Q4 2022 | Feb 28, 2023 · After close | 0.0% |
| Q2 2022 | Sep 30, 2022 · After close | 0.0% |
| Q4 2021 | Feb 28, 2022 | +3.7% |
| Q2 2021 | Aug 31, 2021 | +12.5% |
| Q4 2020 | Feb 25, 2021 | −1.9% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Bell Potter Healthcare Conference 2026 | Conference | 22 slides | Nov 17, 2026 |
| Conference Presentation (November 2025) | Conference | 20 slides | November 2025 |
| Investor Presentation (March 2025) | Investor deck | 29 slides | Mar 7, 2025 |
| Investor Presentation (May 2024) | Investor deck | 21 slides | May 23, 2024 |
| Investor Presentation (October 2023) | Investor deck | 23 slides | Oct 16, 2023 |
| Investor Presentation (May 2023) | Investor deck | 17 slides | May 11, 2023 |
| Investor Presentation (April 2022) | Investor deck | 17 slides | Apr 28, 2022 |
| Investor Presentation (February 2022) | Investor deck | 20 slides | Feb 4, 2022 |
| ShareCafe Small Cap Hidden Gems Webinar 2021 | Conference | 13 slides | Oct 29, 2021 |
| Investor Presentation (September 2021) | Investor deck | 20 slides | Sep 7, 2021 |
All 12 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Houston We Have — Shareholder Meeting (November 2020) | Shareholder meeting | 14 slides | Nov 27, 2020 |
| Houston We Have — Investor Presentation (May 2020) | Investor deck | 14 slides | May 28, 2020 |
Financials
Annual, in AUD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 92.0K | 101.4K | 44.5K | 107.3K | 251.1K | 442.0K | 679.9K | 824.5K | 14.6K | 146.3K |
| Cost of revenue | 16.4M | 3.24M | 2.92M | 7.12M | 3.44M | 2.19M | 1.78M | 568.9K | 635.4K | 753.1K |
| Gross profit | -16.3M | -3.14M | -2.88M | -7.01M | -3.19M | -1.75M | -1.10M | 255.6K | -620.8K | -606.9K |
| Selling, general and administrative | 13.7M | 9.59M | 4.23M | 5.34M | 4.24M | 2.40M | 1.70M | 580.6K | 1.62M | 968.8K |
| Operating income | -19.8M | -13.0M | -5.92M | -6.96M | -6.53M | -3.35M | -2.85M | -338.3K | -2.43M | -1.67M |
| Depreciation and amortization | 549.0K | 577.2K | 603.7K | 607.3K | 640.2K | 270.1K | 129.9K | 87 | 1.47K | 2.66K |
| EBITDA | -19.3M | -12.4M | -5.32M | -6.35M | -5.89M | -3.08M | -2.72M | -338.2K | -2.43M | -1.67M |
| Interest expense | 1.63K | 1.63K | 16.2K | 104.9K | 2.51K | 11.3K | ||||
| Income before tax | -18.6M | -13.3M | -5.41M | -8.27M | -6.49M | -3.41M | -2.68M | -474.9K | -2.00M | -14.3M |
| Income tax | 4 | 3 | -498.6K | -417.9K | -122 | -171.8K | ||||
| Net income | -18.6M | -13.3M | -5.41M | -8.27M | -5.99M | -2.99M | -2.68M | -474.9K | -2.00M | -14.3M |
| Earnings per share, basic | -0.03 | -0.02 | -0.01 | -0.02 | -0.02 | -0.01 | -0.01 | -0.01 | -0.06 | -0.44 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 8.71M | 6.62M | 2.12M | 3.28M | 2.41M | 3.81M | 3.48M | 714.0K | 473.9K | 362.3K |
| Short-term investments | 11.5M | 2 | 1 | |||||||
| Receivables | 148.0K | 214.7K | 100.0K | 636.5K | 270.3K | 350.3K | 85.4K | 157.2K | 313.4K | 514.1K |
| Inventory | -100.0K | 1 | -894 | 0 | 1 | -313.4K | -514.1K | |||
| Current assets | 9.64M | 18.6M | 2.45M | 3.98M | 3.22M | 4.28M | 3.56M | 872.0K | 787.2K | 919.0K |
| Property, plant and equipment | 35.3K | 14.4K | 34.1K | 40.1K | 33.1K | 74.8K | 150 | 240 | 7.00K | |
| Goodwill | 139.2K | 139.2K | 139.2K | 139.2K | ||||||
| Total assets | 13.9M | 23.4M | 8.26M | 10.4M | 10.2M | 10.9M | 4.15M | 876.1K | 789.3K | 940.4K |
| Accounts payable | 763.0K | 224.3K | 375.4K | 109.8K | 239.8K | 259.0K | 50.0K | 108.0K | 64.4K | 162.2K |
| Current liabilities | 2.25M | 615.4K | 1.49M | 3.00M | 2.21M | 1.10M | 1.01M | 1.33M | 930.2K | 548.9K |
| Total debt | 43.8K | 43.8K | 782.7K | 317.7K | ||||||
| Total liabilities | 2.25M | 615.4K | 1.49M | 3.00M | 2.21M | 1.10M | 1.03M | 1.34M | 936.7K | 599.2K |
| Shareholders' equity | 11.6M | 22.8M | 6.77M | 7.38M | 8.02M | 9.84M | 3.12M | -464.7K | -147.4K | 341.2K |
| Shares outstanding | 652.7M | 585.7M | 497.6M | 448.0M | 392.8M | 276.9M | 225.3M | 70.4M | 35.9M | 32.2M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -10.6M | -6.51M | -3.92M | -4.94M | -2.58M | -1.43M | -1.10M | -202.2K | -1.66M | -2.29M |
| Capital spending | -53.0K | -35.8K | -4 | -339.7K | -367.3K | -1.00M | -88.5K | -88.5K | -3.03K | -787 |
| Free cash flow | -10.6M | -6.54M | -3.92M | -5.28M | -2.95M | -2.43M | -1.19M | -202.2K | -1.66M | -2.29M |
| Cash from investing | 11.5M | -11.6M | -59.8K | -367.3K | -1.00M | -342.8K | 0 | 407.0K | 49.2K | |
| Cash from financing | 1.22M | 22.6M | 2.77M | 5.88M | 1.55M | 2.77M | 4.21M | 442.4K | 1.37M | -763.2K |
| Dividends paid | -2.61M | -3.80M | -407.7K | |||||||
| Share buybacks | -187.0K | -168.0K | -153.8K | -407.7K | -407.7K | 1.05M | 1.37K | |||
| Change in cash | 2.09M | 4.50M | -1.16M | 869.5K | -1.41M | 334.9K | 2.76M | 240.2K | 111.6K | 344.8K |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| Cleansing Notice | Nov 19, 2026 | Financing | ASX |
| Application for quotation of securities - EIQ | Nov 19, 2026 | Financing | ASX |
| EchoSolv HF regulatory update | Nov 18, 2026 | Legal or regulatory action | ASX |
| Trading Halt | Nov 18, 2026 | Trading halt or suspension | ASX |
| Pause in Trading | Nov 18, 2026 | Trading halt or suspension | ASX |
| Bell Potter Healthcare Conference Presentation | Nov 16, 2026 | Other filings | ASX |
| Dr Vasum Peiris Appointed as Chief Medical Officer | Nov 15, 2026 | Management or board change | ASX |
| Notification regarding unquoted securities - EIQ | Nov 4, 2026 | Other filings | ASX |
| Quarterly Activities Report & Appendix 4C Cashflow Report | Oct 25, 2026 | Quarterly report | ASX |
| Notice of Annual General Meeting/Proxy Form | Oct 23, 2026 | Meeting notice | ASX |
Show 200 filings
This page holds 200 of 236 filings. Open Filings
Cap table
Built by 6ix from EchoIQ Limited’s releases
- Common shares
- 740,874,779
- Fully diluted
- 740,874,779
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 740,874,779 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 740,874,779 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Dane Brescacin | SVP Regulatory Affairs · Since at least Nov 16, 2026 |
| Dustin Haines | Chief Executive Officer · Since at least Nov 24, 2025 |
| Matthew Dodds | Chief Financial Officer · Since at least Jun 24, 2026 |
| Nick Lubbers | US President and General Manager · Since at least Apr 30, 2026 |
| Patrick O’Shea | Head of Strategy & Operations · Since at least Nov 16, 2026 |
| Sam Dribin | Chief Technology Officer · Since at least Nov 16, 2026 |
Log in to ask 6ix AI your own questions about EchoIQ Limited.